Market Closed -
Nasdaq
01:30:00 04/06/2024 am IST
|
5-day change
|
1st Jan Change
|
1.6
USD
|
+8.84%
|
|
+8.84%
|
+142.42%
|
Fiscal Period: December |
2021
|
2022
|
---|
Capitalization
1 |
105.9
|
110.2
|
Enterprise Value (EV)
1 |
106
|
111.4
|
P/E ratio
|
-2.8
x
|
-10.5
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
EV / Revenue
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
EV / FCF
|
47,43,213
x
|
2,08,59,169
x
|
FCF Yield
|
0%
|
0%
|
Price to Book
|
-26.2
x
|
-16.8
x
|
Nbr of stocks (in thousands)
|
10,600
|
10,600
|
Reference price
2 |
9.990
|
10.40
|
Announcement Date
|
11/04/22
|
31/03/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.232
|
-1.652
|
-62.34
|
-16.12
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.232
|
-1.653
|
-62.34
|
-17.36
|
Net income
1 |
-0.232
|
-1.653
|
-62.34
|
-17.36
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.0133
|
-0.0947
|
-3.565
|
-0.9921
|
Free Cash Flow
|
-
|
-
|
22.33
|
5.285
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/03/21
|
05/03/21
|
11/04/22
|
31/03/23
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 Q3
|
---|
Net sales
1 |
-
|
-
|
-
|
EBITDA
|
-5.223
|
-2.68
|
-
|
EBIT
1 |
-5.223
|
-2.68
|
-2.655
|
Operating Margin
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-67.4
|
-13.03
|
-14.09
|
Net income
1 |
-67.4
|
-13.03
|
-14.09
|
Net margin
|
-
|
-
|
-
|
EPS
2 |
-2.720
|
-0.4900
|
-0.5300
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
24/05/23
|
14/08/23
|
15/04/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
|
-
|
-
|
0.12
|
1.19
|
Net Cash position
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
22.3
|
5.28
|
ROE (net income / shareholders' equity)
|
-
|
156%
|
1,459%
|
199%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-16,759%
|
-1,049%
|
Assets
1 |
-
|
-
|
0.372
|
1.655
|
Book Value Per Share
2 |
-0.0100
|
-0.1100
|
-0.3800
|
-0.6200
|
Cash Flow per Share
|
-
|
-
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/03/21
|
05/03/21
|
11/04/22
|
31/03/23
|
|
1st Jan change
|
Capi.
|
---|
| +142.42% | 5.09Cr | | +15.55% | 12TCr | | +12.66% | 11TCr | | -2.53% | 2.43TCr | | +1.14% | 2.2TCr | | -9.35% | 1.82TCr | | -42.28% | 1.64TCr | | -18.92% | 1.56TCr | | +6.19% | 1.36TCr | | +28.83% | 1.23TCr |
Bio Therapeutic Drugs
|